GlaxoSmithKline | Capital Ordinaire



Ordinary Share Capital Changement Date
AbbVie USD 18M 0 2024-12
Alcon AG USD 20M 0 2025-03
Almirall EUR 214.79M 189.17M 2025-06
Amgen USD 538M 33.04B 2025-06
argenx SE 61.17M 405.3K 2025-06
AstraZeneca USD 1.55B 1.16B 2025-06
Bayer EUR 2.52B 0 2025-03
Biogen USD 146.6M 146.5M 2025-06
Bristol-Myers Squibb USD 2.04B 1.74B 2025-06
Eli Lilly USD 592.6M 200K 2025-03
Fresenius EUR 563M 0 2025-03
Fresenius Medical Care EUR 293.41M 0 2025-03
Galapagos EUR 65.9M 228.04M 2025-06
Genmab DKK 10M 56M 2025-03
Gilead Sciences USD 1.25B 1.24B 2025-03
GlaxoSmithKline GBP 4.15B 2.8B 2025-06
Glaxosmithkline GBP 1.35B 0 2024-12
GRIFOLS EUR 680.41M 560.8M 2025-06
Hikma Pharmaceutical USD 40M 0 2024-12
Lonza CHF 72M 0 2024-12
Merck EUR 565M 397M 2025-03
Merck USD 1.79B 0 2025-03
Novartis USD 793M 0 2024-12
Novo Nordisk 4.44B 3.99B 2025-06
Orion EUR 140.69M 48.49M 2025-06
Pfizer USD 5.68B 5.2B 2025-06
Philips EUR 950.57M 762.57M 2025-06
Recordati EUR 205.56M 179.42M 2025-06
Regeneron Pharmaceuticals USD 106.4M 106.4M 2025-06
Roche Holding CHF 107M 0 2024-06
Sanofi 1.22B 36.5M 2025-06
Smith & Nephew USD 875.96M 700.96M 2025-06
UCB EUR 584M 0 2024-12


GlaxoSmithKline Capital Ordinaire - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Aug 2025.